Your Messages Inbox
Your Article Summary
See Latest ArticlesLonza and Teva Announce Receipt of Regulatory Approval
Teva Pharmaceutical Industries, 05/15/09
Teva Pharmaceutical Industries Ltd. and Lonza Group Ltd. announced that the European Commission granted antitrust approval to the joint venture between the two companies, which was originally announced on January 2009. In their joint venture Teva and Lonza will cooperate to develop, manufacture and market a number of affordable, efficacious and safe generic equivalents of a selected portfolio of biologic pharmaceuticals.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
US FDA approves SEROQUEL XR for add-on treatment of Major Depressive Disorder
AstraZeneca, 12/07/09
FDA Approves Initiation of Clinical Studies in the U.S. for T2000, Taros Proprietary Non-Sedating Barbiturate Compound
Taro Pharmaceuticals USA, 12/07/09
Article Search
Sponsor